Essential fatty acids in the management of impaired nerve function in diabetes

Diabetes

Volumn 46, Issue SUPPL. 2, 1997, Pages

  Horrobin, David F ^a  

^a Scotia Research Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL FATTY ACID; GAMMA LINOLENIC ACID; LINOLEIC ACID;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC NEUROPATHY; FAT INTAKE; FATTY ACID METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NERVE CONDUCTION; NERVE MEMBRANE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030883754     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.2.s90     Document Type: Conference Paper

References (29)

1. Peifer JJ, Holman RT: Essential fatty acids, diabetes and cholesterol. Arch Biochem Biophys 57:520-521, 1955
2. Mercuri O, Peluffo RO, Brenner RR: Depression of microsomal desaturation of linoleic to gamma-linolenic acid in the alloxan diabetic rat. Biochim Biophys Acta 116:407-411, 1966
3. Brenner RR: Nutritional and hormonal factors influencing desaturation of essential fatty acids. Progr Lipid Res 20:41-18, 1982
4. Horrobin DF: Nutritional and medical importance of gamma-linolenic acid. Prog Lipid Res 31:163-194, 1992
5. Horrobin DF: The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 31:181-197, 1988
6. Horrobin DF (Ed.): Treatment of Diabetic Neuropathy: A New Approach. New York, Churchill Livingstone, 1992
7. Jamal GA: The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy. Diabetic Med 11:145-149, 1994
8. 1 modifies nerve conduction and interferes with local anaesthetic action. Prostaglandins 14:103-110, 1977
9. Julu POO: Essential fatty acids prevent slowed nerve conduction velocity in streptozotocin diabetes rats. J Diabetic Complications 2:185-188, 1988
10. Julu POO: Responses of peripheral nerve conduction velocities to treatment with essential fatty acids in diabetic rats: possible mechanisms of action. In Treatment of Diabetic Neuropathy: a New Approach. Horrobin DF, Ed. New York, Churchill Livingstone, 1992, p. 41-62
11. Tomlinson DR, Robinson JP, Compton AM, Keen P: Essential fatty acid treatment: effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats. Diabetologia 32:655-659, 1989
12. Stevens EJ, Lockett MJ, Carrington AL, Tomlinson DR: Essential fatty acids treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus. Diabetologia 36:397-401, 1993
13. Stevens EJ, Carrington AL, Tomlinson DR: Prostacyclin release in experimental diabetes: effects of evening primrose oil. Prostaglandins Leukot Essent Fatty Acids 49:699-706, 1993
14. Cameron NE, Cotter MA, Robertson S: Essential fatty acid diet supplementation: effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats. Diabetes 40:532-539, 1991
15. Dines KC, Cotter MA, Cameron NE: Contrasting effects of treatment with ω-3 and ω-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats. Diabetologia 36:1132-1138, 1993
16. Cameron NE, Cotter MA: Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: evidence from experimental studies. Diabetic Med 10:593-605, 1993
17. Omawari N, Mahmood S, Dewhurst M, Stevens EJ, Tomlinson DR: Deficient nitric oxide is responsible for reduced nerve blood flow in diabetic rats: prevention by essential fatty acids (Abstract). Br J Pharmacol 116:63, 1995
18. Redden PR, Lin XR, Fahey J, Horrobin DF: Stereospecific analysis of the major triacylglycerol species containing gamma-linolenic acid in evening primrose oil and borage oil. J Chromatogr 704:99-111, 1995
19. Dines KC, Cameron NE, Cotter MA: Comparison of the effects of evening primrose oil and triglycerides containing γ-linolenic acid on nerve conduction and blood flow in diabetic rats. J Pharmacol Exp Ther 273:49-55, 1995
20. Dines KC: Effects of Oils Containing Gamma-Linolenic Acid on Nerve Function in Diabetic Rats. PhD thesis. Aberdeen, U.K., University of Aberdeen, 1994
21. Jenkins DK, Mitchell JC, Manku MS, Horrobin DF: Effects of different sources of gamma-linolenic acid on the formation of essential fatty acid and prostanoid metabolites. Med Sci Res 16:525-526, 1988
22. 1 synthesis is altered by dietary gamma-linolenic acid. J Nutr 122:1600-1606, 1992
23. Horrobin DF: Natural does not equal safe. Pharmaceutical Tech Europe December:14-15, 1994
24. Van Doormaal JJ, Idema IG, Muskiet FAJ, Martini IA, Doorenbos H: Effects of short-term high dose intake of evening primrose oil on plasma and cellular fatty acid compositions, α-tocopherol levels, and erythropoiesis in normal and type I (insulin-dependent) diabetic men. Diabetologia 31:576-584, 1988
25. Tilvis RS, Miettinen TA: Fatty acid composition of serum lipids erythrocytes and platelets in insulin-dependent diabetic women. J Clin Endocrol Metab 61:741-745, 1985
26. 2 and serum fatty acid levels. J Pediatr Gastroenterol Nutr 5:878-882, 1986
27. Jamal GA, Carmichael H: The effect of γ linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial. Diabetic Med 7:319-323, 1990
28. The γ-Linolenic Acid Multicenter Trial Group: Treatment of diabetic neuropathy with γ-linolenic acid. Diabetes Care 16:8-15, 1993
29. Cotter MA, Cameron NE, Dines KC: Facilitation between the effects of polyol pathway inhibition and omega-6 essential fatty acid treatment on peripheral nerve function and blood flow in anaesthetized diabetic rats. J Physiol 584:141, 1995